Vivimed Labs Ltd
NSE:VIVIMEDLAB
Vivimed Labs Ltd
NSE:VIVIMEDLAB
Price:
4.95
INR
Market Closed
Market Cap:
₹747.1m
Relative Value
The Relative Value of one
VIVIMEDLAB
stock under the Base Case scenario is
9.78
INR.
Compared to the current market price of 4.95 INR,
Vivimed Labs Ltd
is
Undervalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VIVIMEDLAB
Relative Value
Base Case
9.78
INR
Undervaluation 49%
Multiples Across Competitors
VIVIMEDLAB Competitors Multiples
Vivimed Labs Ltd Competitors
Vivimed Labs Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
747.1m INR | 0.7 | -3.1 | -33.7 | -3.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987.6B USD | 16.5 | 53.1 | 35.7 | 38.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
565.6B USD | 6 | 20.9 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
280.6B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.3B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223.4B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.6B USD | 4.4 | 15 | 10.6 | 12.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK | 5.2 | 15.9 | 11 | 12.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.3 | 14.8 | 7.5 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
97.3B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
